Trial Profile
Effect of ertapenem in an outpatient parenteral antimicrobial therapy (OPAT) setting for targeted TRUSPBx prophylaxis in the setting of MDR E.coli rectal colonization
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Prostatitis; Septicaemia
- Focus Therapeutic Use
- 30 Dec 2015 New trial record